Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors
- Ruggeri, M
- Tosetto, A
- Palandri, F
- Polverelli, N
- Mazzucconi, Mg
- Santoro, C
- Gaidano, G
- Lunghi, M
- Zaja, F
- De Stefano, Valerio (ORCID:0000-0002-5178-5827)
- Sartori, R
- Fazi, P
- Rodeghiero, F.
DOIAbstract
An increased risk of thrombosis has been reported in primary immune thrombocytopenia (ITP) and with the use of thrombopoietin (TPO) receptor agonists, on the basis of population studies using administrative databases
Add to ORKG